Silver R - Search Results

1

Cyclophosphamide versus placebo in scleroderma lung disease.

Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M; Scleroderma Lung Study Research Group. Tashkin DP, et al. Among authors: silver r. N Engl J Med. 2006 Jun 22;354(25):2655-66. doi: 10.1056/NEJMoa055120. N Engl J Med. 2006. PMID: 16790698 Free article. Clinical Trial.

2

Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma.

Ludwicka A, Trojanowska M, Smith EA, Baumann M, Strange C, Korn JH, Smith T, Leroy EC, Silver RM. Ludwicka A, et al. Among authors: silver rm. J Rheumatol. 1992 Nov;19(11):1716-23. J Rheumatol. 1992. PMID: 1491389

3

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.

Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Silver RM, et al. Am J Med. 1990 May;88(5):470-6. doi: 10.1016/0002-9343(90)90425-d. Am J Med. 1990. PMID: 2337105

4

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.

Ohba T, McDonald JK, Silver RM, Strange C, LeRoy EC, Ludwicka A. Ohba T, et al. Among authors: silver rm. Am J Respir Cell Mol Biol. 1994 Apr;10(4):405-12. doi: 10.1165/ajrcmb.10.4.7510986. Am J Respir Cell Mol Biol. 1994. PMID: 7510986

5

The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.

Hertzman PA, Clauw DJ, Kaufman LD, Varga J, Silver RM, Thacker HL, Mease P, Espinoza LR, Pincus T. Hertzman PA, et al. Among authors: silver rm. Ann Intern Med. 1995 Jun 1;122(11):851-5. doi: 10.7326/0003-4819-122-11-199506010-00008. Ann Intern Med. 1995. PMID: 7741371

6

Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.

Bolster MB, Silver RM. Bolster MB, et al. Among authors: silver rm. Curr Opin Rheumatol. 1994 Nov;6(6):642-9. doi: 10.1097/00002281-199411000-00016. Curr Opin Rheumatol. 1994. PMID: 7865387 Review.

7

Failure of the circulatory system limits exercise performance in patients with systemic sclerosis.

Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, Silver RM. Sudduth CD, et al. Among authors: silver rm. Am J Med. 1993 Oct;95(4):413-8. doi: 10.1016/0002-9343(93)90311-c. Am J Med. 1993. PMID: 8213874

8

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.

Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C. Silver RM, et al. J Rheumatol. 1993 May;20(5):838-44. J Rheumatol. 1993. PMID: 8336309 Clinical Trial.

9

Lung disease in systemic sclerosis (scleroderma).

Bolster MB, Silver RM. Bolster MB, et al. Among authors: silver rm. Baillieres Clin Rheumatol. 1993 Feb;7(1):79-97. doi: 10.1016/s0950-3579(05)80269-9. Baillieres Clin Rheumatol. 1993. PMID: 8519079 Review.

10

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.

Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM. Ludwicka A, et al. Among authors: silver rm. J Rheumatol. 1995 Oct;22(10):1876-83. J Rheumatol. 1995. PMID: 8991985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,106 results

Search Page

Filters